SecBot SecBot
DFAN14A ·Filed Feb 27, 2026

MASI

MASIMO CORP
BULLISH
Impact 9/10
Horizonmonths Processed8mo ago SEC0001193125-26-082686
Proxy fight materials (activist)
Actionable Insight ▲ Bullish

Traders should monitor for the upcoming definitive proxy statement, regulatory filings, and potential competing bids. The acquisition could lead to operational synergies and revenue expansion through Danaher's global commercial infrastructure. Consider positioning for deal closure in the coming months, barring regulatory or shareholder hurdles.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$175.27
T+0 close · Feb 27, 2026 · via day close
Latest settled
+1.94%
T+60 · $178.67
Vs SPY
−7.39%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 2 $175.27entry
  2. T+1 · 9mo ago −0.45%α +0.47% · $174.49
  3. T+5 · 8mo ago +0.09%α +1.29% · $175.42
  4. T+20 · 8mo ago +0.99%α +8.93% · $177.00
  5. T+60 · 6mo ago +1.94%α −7.39% · $178.67
Loading chart...

Executive Summary

Danaher Corporation has announced an agreement to acquire Masimo Corporation, a medical technology company specializing in patient monitoring solutions. The DFAN14A filing consists of communications from Danaher leadership to Masimo employees, confirming the proposed transaction and expressing enthusiasm about combining the two organizations to expand global impact in diagnostics and patient care.

Key Facts

  • Danaher Corporation is acquiring Masimo Corporation.
  • The deal is intended to combine Danaher's diagnostics platform with Masimo's patient monitoring and acute care innovations.
  • Julie Sawyer Montgomery, Executive Vice President of Danaher's Diagnostics segment, communicated directly with Masimo employees to affirm commitment and vision.
  • The transaction is subject to regulatory approvals, stockholder approval, and other customary closing conditions.
  • Until closing, Masimo will continue operating independently under current leadership.

Financial Impact

Deal value not disclosed in this filing, but Masimo's market cap is $9.4B as of filing date.

enterprise valuerevenuestrategic direction

Risk Factors

  • Failure to obtain regulatory approvals or Masimo stockholder approval.
  • Potential for competing acquisition offers.
  • Integration risks post-closing.
  • Litigation related to the transaction.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DFAN14A Filing (Primary)0001193125-26-082686
Document: 0001193125-26-082686-index-headers.html0001193125-26-082686
Document: 0001193125-26-082686-index.html0001193125-26-082686
Document: 0001193125-26-082686.txt0001193125-26-082686

Track record

10 reports on MASI

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +0.39% at T+20 after the May 4, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Oct 12, 20265w ago Institutional Cluster Bearish 4/10 No price data
  2. Jun 22, 202621w ago 15-12G Neutral 4/10 No price data
  3. Jun 10, 202622w ago 8-K Bullish 8/10 Entry $179.95 No price data
  4. May 4, 202628w ago 8-K Bullish 8/10 Entry $177.90 to $178.59 ▲ +0.39% −5.26% vs SPY
  5. Apr 21, 202630w ago Court Ruling Bearish 6/10 Entry $178.21 to $178.80 ▼ −0.33% +4.59% vs SPY
  6. Apr 1, 202632w ago DEFM14A Bullish 8/10 Entry $177.95 to $178.46 ▲ +0.28% −9.44% vs SPY
  7. Mar 18, 202634w ago PREM14A Neutral 4/10 Entry $178.51 to $177.96 ▼ −0.31% −7.93% vs SPY
  8. Feb 27, 202637w ago DFAN14A Bullish 9/10 Viewing Entry $175.27 to $177.00 ▲ +0.99% +8.93% vs SPY
  9. Jan 23, 202642w ago Court Ruling Neutral 2/10 Entry $142.48 No price data
  10. Jan 23, 202642w ago Court Ruling Neutral 2/10 Entry $142.48 No price data
Showing 10 of 10

US Market Status

Market Closed · Opens Wed (11h 35m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 27, 2026